These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33086288)

  • 1. Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of pain.
    Beckley JT; Pajouhesh H; Luu G; Klas S; Delwig A; Monteleone D; Zhou X; Giuvelis D; Meng ID; Yeomans DC; Hunter JC; Mulcahy JV
    Pain; 2021 Apr; 162(4):1250-1261. PubMed ID: 33086288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a selective, state-independent inhibitor of Na
    Pajouhesh H; Beckley JT; Delwig A; Hajare HS; Luu G; Monteleone D; Zhou X; Ligutti J; Amagasu S; Moyer BD; Yeomans DC; Du Bois J; Mulcahy JV
    Sci Rep; 2020 Sep; 10(1):14791. PubMed ID: 32908170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.
    Shields SD; Deng L; Reese RM; Dourado M; Tao J; Foreman O; Chang JH; Hackos DH
    J Neurosci; 2018 Nov; 38(47):10180-10201. PubMed ID: 30301756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ST-2560, a selective inhibitor of the Na
    Mulcahy JV; Beckley JT; Klas SD; Odink DA; Delwig A; Pajouhesh H; Monteleone D; Zhou X; Du Bois J; Yeomans DC; Luu G; Hunter JC
    Br J Pharmacol; 2024 Sep; 181(17):3160-3171. PubMed ID: 38715413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.
    Xue Y; Chidiac C; Herault Y; Gaveriaux-Ruff C
    Neurosci Lett; 2021 May; 753():135844. PubMed ID: 33775738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Natural Flavonoid Naringenin Elicits Analgesia through Inhibition of NaV1.8 Voltage-Gated Sodium Channels.
    Zhou Y; Cai S; Moutal A; Yu J; Gómez K; Madura CL; Shan Z; Pham NYN; Serafini MJ; Dorame A; Scott DD; François-Moutal L; Perez-Miller S; Patek M; Khanna M; Khanna R
    ACS Chem Neurosci; 2019 Dec; 10(12):4834-4846. PubMed ID: 31697467
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhang F; Zhang C; Xu X; Zhang Y; Gong X; Yang Z; Zhang H; Tang D; Liang S; Liu Z
    J Biol Chem; 2019 May; 294(18):7324-7334. PubMed ID: 30804211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models.
    Urru M; Muzzi M; Coppi E; Ranieri G; Buonvicino D; Camaioni E; Coppini R; Pugliese AM; Tanaka B; Estacion M; Waxman SG; Dib-Hajj SD; Chiarugi A
    Pain; 2020 Apr; 161(4):831-841. PubMed ID: 31815915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pain and analgesia : Mutations of voltage-gated sodium channels].
    Eberhardt MJ; Leffler A
    Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique electrophysiological property of a novel Nav1.7, Nav1.8, and Nav1.9 sodium channel blocker, ANP-230.
    Kamei T; Kudo T; Yamane H; Ishibashi F; Takada Y; Honda S; Maezawa Y; Ikeda K; Oyamada Y
    Biochem Biophys Res Commun; 2024 Aug; 721():150126. PubMed ID: 38776832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Spider (
    Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel Na
    Gilchrist JM; Yang ND; Jiang V; Moyer BD
    Mol Pharmacol; 2024 Feb; 105(3):233-249. PubMed ID: 38195157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic Effects of Topical Amitriptyline in Patients With Chemotherapy-Induced Peripheral Neuropathy: Mechanistic Insights From Studies in Mice.
    Genevois AL; Ruel J; Penalba V; Hatton S; Petitfils C; Ducrocq M; Principe P; Dietrich G; Greco C; Delmas P
    J Pain; 2021 Apr; 22(4):440-453. PubMed ID: 33227509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoarthritis-dependent changes in antinociceptive action of Nav1.7 and Nav1.8 sodium channel blockers: An in vivo electrophysiological study in the rat.
    Rahman W; Dickenson AH
    Neuroscience; 2015 Jun; 295():103-16. PubMed ID: 25818052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aryl and acylsulfonamides as state-dependent inhibitors of Na
    Zidar N; Tomašič T; Kikelj D; Durcik M; Tytgat J; Peigneur S; Rogers M; Haworth A; Kirby RW
    Eur J Med Chem; 2023 Oct; 258():115530. PubMed ID: 37329714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
    Mulcahy JV; Pajouhesh H; Beckley JT; Delwig A; Du Bois J; Hunter JC
    J Med Chem; 2019 Oct; 62(19):8695-8710. PubMed ID: 31012583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral and somatic pain modalities reveal Na
    Hockley JR; González-Cano R; McMurray S; Tejada-Giraldez MA; McGuire C; Torres A; Wilbrey AL; Cibert-Goton V; Nieto FR; Pitcher T; Knowles CH; Baeyens JM; Wood JN; Winchester WJ; Bulmer DC; Cendán CM; McMurray G
    J Physiol; 2017 Apr; 595(8):2661-2679. PubMed ID: 28105664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No gain, no pain: NaV1.7 as an analgesic target.
    King GF; Vetter I
    ACS Chem Neurosci; 2014 Sep; 5(9):749-51. PubMed ID: 25111714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
    Thériault O; Poulin H; Beaulieu JM; Chahine M
    Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel Na
    Kornecook TJ; Yin R; Altmann S; Be X; Berry V; Ilch CP; Jarosh M; Johnson D; Lee JH; Lehto SG; Ligutti J; Liu D; Luther J; Matson D; Ortuno D; Roberts J; Taborn K; Wang J; Weiss MM; Yu V; Zhu DXD; Fremeau RT; Moyer BD
    J Pharmacol Exp Ther; 2017 Jul; 362(1):146-160. PubMed ID: 28473457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.